User:Steve Withers - Revision history

Harry Brumer: Text replacement - "\^\^\^(.*)\^\^\^" to "$1"

2021-12-18T21:34:51Z

Text replacement - "\^\^\^(.*)\^\^\^" to "$1"

Harry Brumer: standardized picture format

2011-02-08T20:18:30Z

standardized picture format

Spencer Williams at 11:38, 16 June 2010

2010-06-16T11:38:54Z

Harry Brumer at 08:45, 16 February 2010

2010-02-16T08:45:29Z

Harry Brumer at 08:08, 16 February 2010

2010-02-16T08:08:03Z

Harry Brumer: User:Withers moved to User:Steve Withers: Automatically moved page while renaming the user "Withers" to "Steve Withers"

2009-07-28T15:28:35Z

User:Withers moved to User:Steve Withers: Automatically moved page while renaming the user "Withers" to "Steve Withers"

Harry Brumer at 14:57, 1 June 2009

2009-06-01T14:57:25Z

Daniil Naumoff at 09:14, 12 March 2008

2008-03-12T09:14:09Z

Harry Brumer at 18:15, 10 June 2007

2007-06-10T18:15:22Z

Bernard Henrissat at 09:15, 19 May 2007

2007-05-19T09:15:47Z

@@ Line 1: / Line 1: @@
 [[Image:Resize of Resize of withers.jpg|200px|right]]
-'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing <sup>31</sup>P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (^^^Bernard Henrissat^^^, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
+'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing <sup>31</sup>P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille ([[User:Bernard Henrissat|Bernard Henrissat]], 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
 [[Category:Contributors|Withers, Steve]]

@@ Line 1: / Line 1: @@
-[[Image:Resize of Resize of withers.jpg|right]]
+[[Image:Resize of Resize of withers.jpg|200px|right]]
 '''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing <sup>31</sup>P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (^^^Bernard Henrissat^^^, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
 [[Category:Contributors|Withers, Steve]]

@@ Line 1: / Line 1: @@
 [[Image:Resize of Resize of withers.jpg|right]]
-'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (^^^Bernard Henrissat^^^, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
+'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing <sup>31</sup>P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (^^^Bernard Henrissat^^^, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
 [[Category:Contributors|Withers, Steve]]

@@ Line 1: / Line 1: @@
 [[Image:Resize of Resize of withers.jpg|right]]
-'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
+'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (^^^Bernard Henrissat^^^, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
 [[Category:Contributors|Withers, Steve]]

@@ Line 1: / Line 1: @@
 [[Image:Resize of Resize of withers.jpg|right]]
-'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
+'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase ([[GH2]]). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
 [[Category:Contributors|Withers, Steve]]

← Older revision	Revision as of 15:28, 28 July 2009
(No difference)

← Older revision		Revision as of 14:57, 1 June 2009
Line 3:		Line 3:
	'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.		'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.

−	[[Category:~~Biographies~~\|Withers, Steve]]	+	[[Category:Contributors\|Withers, Steve]]

← Older revision		Revision as of 09:14, 12 March 2008
Line 2:		Line 2:

	'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.		'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
		+
		+	[[Category:Biographies\|Withers, Steve]]

← Older revision		Revision as of 18:15, 10 June 2007
Line 1:		Line 1:
		+	[[Image:Resize of Resize of withers.jpg\|right]]
		+
	'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.		'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
−
−
−	~~[[Image:Resize of Resize of withers.jpg]]~~

← Older revision		Revision as of 09:15, 19 May 2007
Line 1:		Line 1:
	'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.		'''Steve Withers''' obtained his BSc in Chemistry from the University of Bristol, U.K. in 1974, then completed his PhD at Bristol with Mike Sinnott in 1977, working on the catalytic mechanism of ''E. coli'' (lac z) Beta-galactosidase (GH2). His postdoctoral fellowship was carried out at the University of Alberta, Edmonton, Canada, working with Neil Madsen and Brian Sykes doing 31P-NMR studies on the role of PLP in the mechanism of glycogen phosphorylase (GT35). In 1982 he moved as Assistant Professor to the Department of Chemistry, University of British Columbia and now holds the Khorana Chair in Chemistry and Biochemistry at UBC. During this time he has spent sabbatical leaves at the University of Oxford (Louise Johnson, 1991/2: Raymond Dwek, 1998/9) and AFMB, Marseille (Bernard Henrissat, 2006/7). His research interests concern mechanisms of glycosidases and glycosyl transferases, engineering of these enzymes, particularly for enzymatic glycoside synthesis (glycosynthases and thioglycoligases), and development of inhibitors as potential pharmaceuticals.
		+
		+
	[[Image:Resize of Resize of withers.jpg]]		[[Image:Resize of Resize of withers.jpg]]